Abstract:Background Ischemic stroke frequently leads to a condition known as post-stroke cognitive impairment (PSCI). Timely recognition of individuals susceptible to developing PSCI could facilitate the implementation of personalized strategies to mitigate cognitive deterioration. High mobility group box 1 (HMGB1) is a protein released by ischemic neurons and implicated in inflammation after stroke. Circulating levels of HMGB1 could potentially serve as a prognostic indicator for the onset of cognitive impairment following ischemic stroke. Objective To investigate the predictive value of circulating HMGB1 concentrations in the acute phase of ischemic stroke for the development of cognitive dysfunction at the 3-month follow-up. Methods A total of 192 individuals experiencing their initial episode of acute cerebral infarction were prospectively recruited for this longitudinal investigation. Concentrations of circulating HMGB1 were quantified using an enzyme-linked immunosorbent assay (ELISA) technique within the first 24 hours following hospital admission. Patients underwent neurological evaluation including NIHSS scoring. Neuropsychological evaluation was conducted at the 3-month follow-up after the cerebrovascular event, employing the Montreal Cognitive Assessment (MoCA) as the primary tool for assessing cognitive performance. Multivariable logistic regression models were employed to investigate the relationship between circulating HMGB1 concentrations and cognitive dysfunction following stroke, which was operationalized as a MoCA score below 26, while controlling for potential confounders including demographic characteristics, stroke severity, vascular risk factors, and laboratory parameters. Results Of 192 patients, 84 (44%) developed PSCI. Circulating HMGB1 concentrations were significantly elevated in individuals who developed cognitive dysfunction following stroke compared to those who maintained cognitive integrity (8.4 ± 1.2 ng/mL vs 4.6 ± 0.5 ng/mL, respectively; p < 0.001). The prevalence of PSCI showed a dose-dependent increase with higher HMGB1 quartiles. After controlling for potential confounders such as demographic factors (age, gender, and education), stroke severity, vascular risk factors, and laboratory parameters in a multivariable logistic regression model, circulating HMGB1 concentrations emerged as a significant independent predictor of cognitive dysfunction following stroke (regression coefficient = 0.236, p < 0.001). Conclusion Circulating HMGB1 concentrations quantified within the first 24 hours following acute cerebral infarction are significantly and independently correlated with the likelihood of developing cognitive dysfunction at the 3-month follow-up, even after accounting for potential confounding factors. HMGB1 may be a novel biomarker to identify patients likely to develop post-stroke cognitive impairment for targeted preventive interventions.

Risk Factors for Early-Stage Cognitive Deterioration after Ischemic Stroke

Correlation of Posterior Cerebral Artery Ischemic Stroke and Cognitive Impairment

Correlation of Stress Hyperglycemia after Ischemic Stroke with Early Vascular Cognitive Impairment

Low Serum Superoxide Dismutase is Associated with a High Risk of Cognitive Impairment after Mild Acute Ischemic Stroke

A Risk Factor Analysis of Cognitive Impairment in Elderly Patients with Chronic Diseases in a Chinese Population

Frequency and Risk Factors of Vascular Cognitive Impairment Three Months after Ischemic Stroke in China: The Chongqing Stroke Study

Incidence and risk factors of cognitive impairment 3 months after first-ever stroke: A cross-sectional study of 5 geographic areas of China

Evaluation of the Mini-Mental State Examination and the Montreal Cognitive Assessment for Predicting Post-stroke Cognitive Impairment During the Acute Phase in Chinese Minor Stroke Patients

Relatedl Factors of Cognitive Impairment after Stroke

Early Neurological Deterioration in Patients with Acute Ischemic Stroke: a Prospective Multicenter Cohort Study

Early biomarkers for post-stroke cognitive impairment

Relation between sleep disorders and post-stroke cognitive impairment

Incidence and influencing factors of post-stroke cognitive impairment in convalescent young patients with first-ever stroke

Predictors of Cognitive Impairment after Stroke: A Prospective Stroke Cohort Study.

Influencing Factors of Vascular Cognitive Impairment Among Patients With Ischemic Stroke

Abstract WP563: Risk Factors Related to the Development of Post Stroke Cognitive Impairment in Shanghai Stroke Population

Characteristics and risk factors analysis of cognitive decline in elderly patients with cerebral infarction

Circulating HMGB1 in acute ischemic stroke and its association with post-stroke cognitive impairment

Cognitive Impairment in Stroke Patients with Non-strategic Infarcts

Meta-Analysis of Risk Factors of Vascular Cognitive Disorder in Acute Cerebral Infarction Patients

Risk Factors in 174 Patients with Acute Ischemic Stroke